Top

Top
bottom

Top
bottom

Top
bottom

Top
bottom

eFoodSafety Provides Product Update

eFoodSafety.com, Inc., based in Scottsdale, Arizona, is dedicated to improving health conditions around the world through its innovative technologies. The company’s Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product, Citroxin(tm) (formerly named Big Six Plus) EPA Reg. No. 82723-1 that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The OraPhyte product, which has been tested and shown to be effective at eradicating nematodes by the U.S. Department of Agriculture, is currently at three major universities with outstanding Agricultural Departments undergoing crop-specific research.

The company’s Cinnergen is a clinically-studied, non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism, is available for sale at (www.cinnergen.com) and through national retailers; its Cinnechol(tm) is a multi-faceted nutritional supplement specifically designed to naturally reduce total cholesterol levels without causing any side effects. The company has entered into a joint venture agreement with CK41 Direct, Inc. to launch the PurEffect anti-acne skin care system.

The company’s iBoost, Inc. subsidiary is the distributor of the Immune Boost Bar(tm), a non-dairy, no refined sugar, all-natural and comprehensive multi-nutrient product that helps fortify the body’s immune system. The product contains Citroxin(tm), eFoodSafety’s proprietary all natural supplement proven effective in fighting several types of harmful bacteria, and forty active compounds that assist with enhancing immunity, detoxification, cleansing, and metabolic efficiency. The Immune Boost Bar(tm) is available in three delicious flavors: chocolate, oatmeal-raisin, mint and peanut butter and can be purchased at www.immuneboost.com.

The company’s MedElite, Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It is the owner of the Talsyn(tm)-CI/bid Scar Cream, a product that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com), as well as seven (7) other products in the Talsyn line.

Products

Why Invest in eFoodSafety.com, Inc.?

  • eFoodSafety (EFSF) is about to turn the corner to commercialization, with its soon-to-be launched direct-response campaigns and its entrance in the functional food market through retail distribution of its Immune Boost Bar(TM).
  • eFoodSafety has established commercialization plans and launched numerous products that can provide a diversified stream of revenues in markets with significant growth.
  • EFSF has entered the functional food market, an estimated $3 billion per year market, with its Immune Boost Bar(TM), through a national sales and marketing campaign led by industry-experienced CPG Focus Consulting.
  • EFSF has shown significant progress during FY’07 including a more than 100% increase in revenues year-over-year and improvements to the balance sheet.
  • In addition to product rollout and direct marketing campaigns for current products, eFoodSafety has additional products in the pipeline, including Oraphyte(TM), which has been tested by the U.S. Department of Agriculture and shown to be effective at eradication of nematodes, as well at Citroxin(TM), which has been shown to kill six major bacteria.

SmallCapVoice.com is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities members should buy or sell for themselves. Members should always check with their licensed financial advisor and their tax advisor to determine the suitability of any investment. This Newsletter is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible. Moreover this publication accepts compensation from some of the companies which it features. For compensation and complete disclaimer click here.